Jardiance is a prescription medication used for several important health conditions, including type 2 diabetes, heart failure, and certain forms of chronic kidney disease. For people enrolled in Medicare, the cost of Jardiance depends largely on the type of Medicare coverage, the specific prescription drug plan, the pharmacy used, and the medication's placement on the plan formulary.
Medicare can cover Jardiance when it is prescribed for a medically appropriate indication and the Medicare plan includes the medication on its formulary.
Jardiance is generally handled as a prescription drug under Medicare Part D rather than as a medication paid directly through Original Medicare Part B.
Medicare Part D is administered through private Medicare-approved prescription drug plans. Medicare Advantage plans that include prescription drug coverage can also cover Jardiance.
Because individual plans establish their own formularies and cost-sharing structures, coverage can differ from one plan to another.
A prescription for Jardiance does not automatically mean that every Medicare plan will charge the same amount.
For most people, Jardiance falls under Medicare Part D prescription drug coverage.
Original Medicare consists primarily of Part A and Part B. Prescription medications taken at home are generally not covered by Original Medicare unless they fall under specific circumstances.
Part D provides prescription drug coverage through private Medicare-approved plans. Medicare Advantage plans can also include Part D benefits.
For a person taking Jardiance regularly, Part D coverage is therefore an important part of determining the medication's annual cost.
Medicare Advantage plans, also known as Medicare Part C, frequently include prescription drug coverage.
When a Medicare Advantage plan includes Part D benefits, Jardiance may be covered according to that plan's formulary.
The amount paid can depend on:
Two Medicare Advantage plans can therefore provide different costs for the same Jardiance prescription.
Medicare prescription plans generally divide covered medications into tiers.
Lower tiers commonly have lower cost-sharing, while higher tiers can have higher copayments or coinsurance.
Brand-name medications such as Jardiance may be placed on a preferred or non-preferred brand tier depending on the plan.
The formulary can change from year to year. A medication's tier in one plan year does not necessarily determine its tier in another year.
For 2026, the specific plan formulary is the most reliable source for determining Jardiance's cost-sharing.
Jardiance was selected by CMS for the first Medicare Drug Price Negotiation Program cycle. CMS's original 2026 selection list identifies Jardiance among the 10 Part D drugs selected for negotiation.
This is an important distinction because the negotiated Medicare price became effective January 1, 2026 for selected drugs in the first negotiation cycle.
Jardiance was included in that first group, along with medications such as Eliquis, Xarelto, Januvia, Farxiga, and Entresto.
However, the negotiated maximum fair price should not be interpreted as a universal retail price for every Medicare enrollee. Actual patient costs can still depend on the prescription drug plan, coverage structure, pharmacy, and other Medicare rules.
There is no single Medicare price for Jardiance.
The final amount can vary based on the Part D or Medicare Advantage plan, deductible, formulary tier, pharmacy, and the stage of prescription drug coverage.
Medicare states that Part D plans can use premiums, deductibles, copayments, and coinsurance to determine prescription drug costs.
For 2026, a Part D deductible cannot exceed $615. After the deductible and during the initial coverage stage, covered Part D drugs generally have 25% coinsurance until annual out-of-pocket spending reaches $2,100. Once the $2,100 threshold is reached, catastrophic coverage begins and covered Part D drugs have no out-of-pocket cost for the remainder of the calendar year.
This means the amount paid for Jardiance can change during the year depending on how much has already been spent on covered prescriptions.
Several factors can influence the final prescription cost.
A plan may place Jardiance on a preferred brand tier or another tier with different cost-sharing.
Some plans require part or all of a prescription deductible before regular copayments begin.
A plan may charge a fixed amount for a covered prescription.
Instead of a fixed copayment, some plans may require a percentage of the plan's allowed cost.
The pharmacy used to fill the prescription can affect the amount paid.
Some plans provide different cost structures for 90-day prescriptions through mail-order pharmacies.
Prior authorization, quantity limits, or step-therapy requirements may apply under certain formularies.
One of the major Medicare prescription drug changes for 2026 is the $2,100 annual out-of-pocket limit for covered Part D medications.
Once qualifying out-of-pocket spending reaches $2,100 during the calendar year, catastrophic coverage begins.
At that point, Medicare states that there is no out-of-pocket cost for covered Part D drugs for the remainder of the year.
For people taking multiple expensive prescriptions, this annual limit can be particularly important.
A person taking Jardiance along with other covered medications may reach the annual threshold sooner than someone taking only one relatively inexpensive prescription.
Medicare also has a Prescription Payment Plan that allows eligible Part D enrollees to spread covered prescription out-of-pocket costs across the calendar year.
The program does not reduce the total amount owed. Instead, it changes the timing of payments by spreading eligible expenses across monthly payments.
This can be useful for people who face large prescription costs during one part of the year.
Medicare notes that participation is voluntary and works with existing Medicare prescription drug coverage.
People with limited income and resources may qualify for Medicare's Extra Help program.
Extra Help can assist with Part D premiums, deductibles, copayments, and other prescription drug expenses.
Some people receive Extra Help automatically. Medicare states that automatic qualification can apply to people receiving Supplemental Security Income, people with full-benefit Medicaid, and certain people enrolled in Medicare Savings Programs.
For 2026, Medicare lists income and resource limits for people who do not automatically qualify.
The program can be particularly important for Medicare beneficiaries who take Jardiance along with several other prescription medications.
Some people qualify for both Medicare and Medicaid.
For individuals with dual eligibility, Medicaid can provide additional assistance with medical and prescription expenses depending on state rules.
Medicare also identifies Medicaid as one of the programs that may help reduce drug costs.
Coordination between Medicare and Medicaid can vary by individual circumstances and state program rules.
Jardiance, whose active ingredient is empagliflozin, is an SGLT2 inhibitor.
It is used alongside diet and exercise to improve blood glucose control in people with type 2 diabetes. It also has approved uses related to cardiovascular and kidney outcomes.
The reason for prescribing Jardiance can therefore influence the clinical documentation associated with the prescription.
A physician or other qualified prescriber determines whether Jardiance is medically appropriate based on the patient's health circumstances.
Jardiance is also approved to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
This indication means Jardiance can be prescribed even when the primary reason for treatment is not blood sugar control.
Medicare coverage remains dependent on the individual's prescription drug plan and applicable coverage rules.
Jardiance also has an approved indication for certain adults with chronic kidney disease who are at risk of progression.
The medication can reduce the risk of sustained decline in kidney function, end-stage kidney disease, cardiovascular death, and hospitalization in qualifying patients.
Coverage and clinical eligibility remain separate issues. A medication can have an FDA-approved indication while a particular Medicare plan may still impose formulary or utilization-management requirements.
Some Medicare drug plans may require prior authorization or other utilization-management procedures for Jardiance.
Prior authorization means the plan requires information from the prescriber before agreeing to cover the medication under specified circumstances.
The exact requirements depend on the individual plan.
A plan can also establish quantity limits or require certain clinical criteria.
If a prescription is rejected, the reason for the rejection should be reviewed because different coverage problems can require different solutions.
If a Medicare plan does not cover Jardiance or places significant restrictions on the prescription, several administrative pathways may exist.
A prescriber may be able to request an exception or submit supporting medical information when appropriate.
A formal appeal may also be possible when a Medicare plan denies coverage for a medication.
The appropriate process depends on the reason for the denial and the plan's rules.
A pharmacist can also identify whether the prescription is being processed under the correct Medicare plan and whether the pharmacy is participating in the plan's network.
The most reliable way to determine the exact Jardiance cost is to review the specific Medicare plan.
Important information includes:
Medicare's plan comparison tool can be used to review Medicare health and drug plans and compare prescription coverage.
Yes.
Medicare Part D plans can change formularies and cost-sharing from one plan year to another.
A prescription that had one copayment in a previous year may have a different cost in 2026.
For that reason, checking the current year's formulary is more useful than relying on an older prescription cost.
A plan's annual materials can provide information about formulary changes, tier placement, and cost-sharing.
Jardiance is the brand name for empagliflozin.
The existence of a generic alternative can have a significant effect on prescription coverage, but formulary treatment depends on whether a therapeutically appropriate generic is actually covered and whether the prescriber considers it suitable.
Medication substitutions should not be made without consultation with the prescribing clinician or pharmacist.
The active ingredient, dose, indication, and formulation all matter when comparing medications.
Manufacturer assistance programs have their own eligibility rules.
Some manufacturer programs are designed for people without certain types of insurance and may exclude people who have government-sponsored coverage.
Medicare notes that pharmaceutical assistance programs exist, but each program establishes its own requirements.
Therefore, eligibility for a manufacturer program should be checked carefully rather than assuming that a commercial discount applies to a Medicare prescription.
Medicare coverage and the amount paid at the pharmacy are not the same thing.
A plan can cover Jardiance while still requiring a deductible, copayment, or coinsurance.
For example, two beneficiaries could both have Medicare Part D coverage for Jardiance but pay different amounts because they have different plans, different deductibles, or different formulary tiers.
The annual $2,100 Part D out-of-pocket limit provides an important ceiling for qualifying covered prescription expenses in 2026, but it does not mean that every Jardiance prescription will cost the same amount throughout the year.
Before filling a prescription, several questions can help clarify the expected cost:
Getting these details directly from the plan can provide a more accurate estimate than relying on a general national price.
Many Medicare prescription drug plans cover Jardiance, but coverage and cost-sharing depend on the specific Part D or Medicare Advantage plan.
For most people taking Jardiance as a prescription medication, coverage falls under Medicare Part D rather than Original Medicare Part B.
Yes. Jardiance was one of the 10 Part D drugs selected for the first Medicare Drug Price Negotiation Program cycle, with negotiated pricing taking effect in 2026.
The annual out-of-pocket limit for covered Part D prescription drugs is $2,100 in 2026. After reaching that limit, covered Part D drugs have no out-of-pocket cost for the remainder of the calendar year.
Extra Help can reduce Medicare Part D prescription expenses for qualifying beneficiaries, including premiums, deductibles, and cost-sharing.
No. Costs can vary by plan, formulary tier, deductible, pharmacy network, and other coverage rules.
Medicare coverage for Jardiance in 2026 is influenced by several factors, but Part D prescription drug coverage is generally the key component for people receiving Jardiance from a retail or mail-order pharmacy.
One of the most significant developments for 2026 is that Jardiance was included among the first 10 drugs selected for Medicare price negotiation. The negotiated pricing structure took effect January 1, 2026.